BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35961859)

  • 1. The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.
    De Luca G; Cerruti G; Lastraioli S; Conte R; Ibatici A; Di Felice N; Morabito F; Monti P; Fronza G; Matis S; Colombo M; Fabris S; Ciarrocchi A; Neri A; Menichini P; Ferrarini M; Nozza P; Fais F; Cutrona G; Dono M
    Hematol Oncol; 2022 Dec; 40(5):962-975. PubMed ID: 35961859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.
    Nadeu F; Delgado J; Royo C; Baumann T; Stankovic T; Pinyol M; Jares P; Navarro A; Martín-García D; Beà S; Salaverria I; Oldreive C; Aymerich M; Suárez-Cisneros H; Rozman M; Villamor N; Colomer D; López-Guillermo A; González M; Alcoceba M; Terol MJ; Colado E; Puente XS; López-Otín C; Enjuanes A; Campo E
    Blood; 2016 Apr; 127(17):2122-30. PubMed ID: 26837699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and Functional Analysis of TP53 Mutations in CLL.
    Pavlova S; Smardova J; Tom N; Trbusek M
    Methods Mol Biol; 2019; 1881():63-81. PubMed ID: 30350198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia.
    Quijada-Álamo M; Pérez-Carretero C; Hernández-Sánchez M; Rodríguez-Vicente AE; Herrero AB; Hernández-Sánchez JM; Martín-Izquierdo M; Santos-Mínguez S; Del Rey M; González T; Rubio-Martínez A; García de Coca A; Dávila-Valls J; Hernández-Rivas JÁ; Parker H; Strefford JC; Benito R; Ordóñez JL; Hernández-Rivas JM
    Clin Transl Med; 2021 Feb; 11(2):e304. PubMed ID: 33634999
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Bomben R; Rossi FM; Vit F; Bittolo T; D'Agaro T; Zucchetto A; Tissino E; Pozzo F; Vendramini E; Degan M; Zaina E; Cattarossi I; Varaschin P; Nanni P; Berton M; Braida A; Polesel J; Cohen JA; Santinelli E; Biagi A; Gentile M; Morabito F; Fronza G; Pozzato G; D'Arena G; Olivieri J; Bulian P; Pepper C; Hockaday A; Schuh A; Hillmen P; Rossi D; Chiarenza A; Zaja F; Di Raimondo F; Del Poeta G; Gattei V
    Clin Cancer Res; 2021 Oct; 27(20):5566-5575. PubMed ID: 34285062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
    Rigolin GM; Saccenti E; Bassi C; Lupini L; Quaglia FM; Cavallari M; Martinelli S; Formigaro L; Lista E; Bardi MA; Volta E; Tammiso E; Melandri A; Urso A; Cavazzini F; Negrini M; Cuneo A
    J Hematol Oncol; 2016 Sep; 9(1):88. PubMed ID: 27633522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 mutation analysis in clinical practice: lessons from chronic lymphocytic leukemia.
    Malcikova J; Pavlova S; Kozubik KS; Pospisilova S
    Hum Mutat; 2014 Jun; 35(6):663-71. PubMed ID: 24415659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.
    László T; Kotmayer L; Fésüs V; Hegyi L; Gróf S; Nagy Á; Kajtár B; Balogh A; Weisinger J; Masszi T; Nagy Z; Farkas P; Demeter J; Istenes I; Szász R; Gergely L; Sulák A; Borbényi Z; Lévai D; Schneider T; Pettendi P; Bodai E; Szerafin L; Rejtő L; Bátai Á; Dömötör MÁ; Sánta H; Plander M; Szendrei T; Hamed A; Lázár Z; Pauker Z; Radványi G; Kiss A; Körösmezey G; Jakucs J; Dombi PJ; Simon Z; Klucsik Z; Gurzó M; Tiboly M; Vidra T; Ilonczai P; Bors A; Andrikovics H; Egyed M; Székely T; Masszi A; Alpár D; Matolcsy A; Bödör C
    J Pathol Clin Res; 2024 Jan; 10(1):e351. PubMed ID: 37987115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.
    Amin NA; Seymour E; Saiya-Cork K; Parkin B; Shedden K; Malek SN
    Clin Cancer Res; 2016 Sep; 22(17):4525-35. PubMed ID: 27060156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia.
    Malcikova J; Stano-Kozubik K; Tichy B; Kantorova B; Pavlova S; Tom N; Radova L; Smardova J; Pardy F; Doubek M; Brychtova Y; Mraz M; Plevova K; Diviskova E; Oltova A; Mayer J; Pospisilova S; Trbusek M
    Leukemia; 2015 Apr; 29(4):877-85. PubMed ID: 25287991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia.
    Quijada-Álamo M; Hernández-Sánchez M; Robledo C; Hernández-Sánchez JM; Benito R; Montaño A; Rodríguez-Vicente AE; Quwaider D; Martín AÁ; García-Álvarez M; Vidal-Manceñido MJ; Ferrer-Garrido G; Delgado-Beltrán MP; Galende J; Rodríguez JN; Martín-Núñez G; Alonso JM; García de Coca A; Queizán JA; Sierra M; Aguilar C; Kohlmann A; Hernández JÁ; González M; Hernández-Rivas JM
    J Hematol Oncol; 2017 Apr; 10(1):83. PubMed ID: 28399885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness.
    Rigolin GM; Formigaro L; Cavallari M; Quaglia FM; Lista E; Urso A; Guardalben E; Martinelli S; Saccenti E; Bassi C; Lupini L; Bardi MA; Volta E; Tammiso E; Melandri A; Negrini M; Cavazzini F; Cuneo A
    Oncotarget; 2017 Apr; 8(17):28008-28020. PubMed ID: 28427204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options.
    Malcikova J; Pavlova S; Kunt Vonkova B; Radova L; Plevova K; Kotaskova J; Pal K; Dvorackova B; Zenatova M; Hynst J; Ondrouskova E; Panovska A; Brychtova Y; Zavacka K; Tichy B; Tom N; Mayer J; Doubek M; Pospisilova S
    Blood; 2021 Dec; 138(25):2670-2685. PubMed ID: 33945616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of TP53 for CLL diagnostics.
    Catherwood MA; Gonzalez D; Donaldson D; Clifford R; Mills K; Thornton P
    J Clin Pathol; 2019 May; 72(5):343-346. PubMed ID: 30712002
    [No Abstract]   [Full Text] [Related]  

  • 15. Deep targeted sequencing of
    Brieghel C; Kinalis S; Yde CW; Schmidt AY; Jønson L; Andersen MA; da Cunha-Bang C; Pedersen LB; Geisler CH; Nielsen FC; Niemann CU
    Haematologica; 2019 Apr; 104(4):789-796. PubMed ID: 30514802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia.
    Rossi D; Khiabanian H; Spina V; Ciardullo C; Bruscaggin A; Famà R; Rasi S; Monti S; Deambrogi C; De Paoli L; Wang J; Gattei V; Guarini A; Foà R; Rabadan R; Gaidano G
    Blood; 2014 Apr; 123(14):2139-47. PubMed ID: 24501221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of TP53 mutations in Chinese patients with chronic lymphocytic leukemia is independent of del(17p13).
    Dong HJ; Zhou LT; Zhu DX; Wang DM; Fang C; Zhu HY; Zhuang Y; Miao KR; Xu W; Li JY
    Ann Hematol; 2011 Jun; 90(6):709-17. PubMed ID: 21113594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing.
    Minervini CF; Cumbo C; Orsini P; Brunetti C; Anelli L; Zagaria A; Minervini A; Casieri P; Coccaro N; Tota G; Impera L; Giordano A; Specchia G; Albano F
    Diagn Pathol; 2016 Oct; 11(1):96. PubMed ID: 27724982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ultra-deep sequencing strategy to detect sub-clonal TP53 mutations in presentation chronic lymphocytic leukaemia cases using multiple polymerases.
    Worrillow L; Baskaran P; Care MA; Varghese A; Munir T; Evans PA; O'Connor SJ; Rawstron A; Hazelwood L; Tooze RM; Hillmen P; Newton DJ
    Oncogene; 2016 Oct; 35(40):5328-5336. PubMed ID: 27041575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
    Chiaretti S; Tavolaro S; Marinelli M; Messina M; Del Giudice I; Mauro FR; Santangelo S; Piciocchi A; Peragine N; Truong S; Patten N; Ghia EM; Torrente I; De Propris MS; Nanni M; Lawrence J; Guarini A; Foà R
    Genes Chromosomes Cancer; 2011 Apr; 50(4):263-74. PubMed ID: 21319261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.